Woolley JD

Translational Psychedelic Research Program, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco.

18 papers · ORCID

ArticlePsilocybin

An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.

Downey AE, Szigeti B, Bradley ER +11

Europe PMC2026
ArticlePsychedelics

The Case for More Aggressive Masking in Psychedelic Trials.

Yang KH, Heifets BD, Krystal A +1

Europe PMC2026
ArticlePsilocybin

A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.

Tai ML, Szigeti B, Downey AE +12

Europe PMC2026
ArticlePsychedelics

Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically.

Aday JS, Glynos NG, Baker AK +7

Europe PMC2026
ArticlePsychedelics

Development of a mandarin version of the five dimensional altered states of consciousness (5D-ASC) rating scale.

Aday JS, Zong Z, Song J +2

Europe PMC2026
ArticlePsilocybin

Sudden Loss of Consciousness Following Psilocybin Ingestion.

Downey AE, Tai ML, Bradley ER +1

Europe PMC2025
ArticleMDMA

A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans.

Peled-Avron L, Aday JS, Pantoni MM +2

Europe PMC2025
ArticlePsychedelics

Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents.

Forsberg S, Downey AE, Bruett LD +5

Europe PMC2025
ArticlePsilocybin

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.

Bradley ER, Sakai K, Fernandes-Osterhold G +15

Europe PMC2025
ArticlePsilocybin

Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.

Wolfgang AS, McClair VL, Schnurr PP +13

Europe PMC2025
ArticleDMT

Editorial: Down the rabbit hole - the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions.

Peled-Avron L, Aday JS, Kalafateli AL +2

Europe PMC2024
ArticlePsilocybin

Psychedelic-assisted psychotherapy: where is the psychotherapy research?

Aday JS, Horton D, Fernandes-Osterhold G +4

Europe PMC2024
ArticlePsilocybin

Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.

Sakai K, Bradley ER, Zamaria JA +9

Europe PMC2024
ArticleAyahuasca

Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.

Aday JS, Bloesch EK, Davis AK +4

Europe PMC2025
ArticleMDMA

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Mitchell JM, Bogenschutz M, Lilienstein A +35

Europe PMC2023
ArticlePsilocybin

Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.

Aday JS, Skiles Z, Eaton N +6

Europe PMC2023
ArticlePsychedelics

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.

Aday JS, Heifets BD, Pratscher SD +3

Europe PMC2022
ArticlePsilocybin

Psychedelic-Assisted Group Therapy: A Systematic Review.

Trope A, Anderson BT, Hooker AR +3

Europe PMC2019